Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

President and CEO

Vice President

VP and Head of Japanese Office

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. The company's product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic and other diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. It has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. The company was incorporated in 2000 and is headquartered in La Jolla, California.

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious di...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2022-11-28	Premium	sold	Premium	Premium	Premium	-
2022-11-22	Premium	sold	Premium	Premium	Premium	-
2022-11-21	Premium	sold	Premium	Premium	Premium	-
2022-11-17	Premium	sold	Premium	Premium	Premium	-
2021-08-23	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2021-07-09	Premium	acquired	Premium	Premium	Premium	President and CEO
2021-06-24	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2021-05-19	Premium	acquired	Premium	Premium	Premium	Vice President
2021-03-11	Premium	sold	Premium	Premium	Premium	-
2021-02-25	Premium	acquired	Premium	Premium	Premium	President and CEO
2020-09-15	Premium	sold	Premium	Premium	Premium	-
2020-08-06	Premium	acquired	Premium	Premium	Premium	-
2020-06-12	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2020-04-08	Premium	acquired	Premium	Premium	Premium	President and CEO
2020-04-08	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2020-03-13	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2020-03-12	Premium	bought	Premium	Premium	Premium	President and CEO
2019-06-12	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2019-05-13	Premium	acquired	Premium	Premium	Premium	-
2019-02-28	Premium	acquired	Premium	Premium	Premium	VP and Head of Japanese Office
2019-01-09	Premium	acquired	Premium	Premium	Premium	VP and Head of Japanese Office
2019-01-03	Premium	acquired	Premium	Premium	Premium	President and CEO

MNOV - MediciNova Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for MNOV